Patents by Inventor Emmanuelle Briard

Emmanuelle Briard has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pet imaging agents
    Patent number: 10865195
    Abstract: Preparation of novel 2-benzyl-5-methyl-2H-tetrazole derivatives of the formula (I) for use as PET imaging agents. The present invention relates to novel compounds of formula (I) their preparation and use as PET imaging agents for imaging techniques and diagnostics in the field of diseases and disorders mediated by or related to the enzyme autotaxin.
    Type: Grant
    Filed: September 24, 2019
    Date of Patent: December 15, 2020
    Assignee: Novartis AG
    Inventors: Yves Auberson, Emmanuelle Briard, Darren Le Grand, Berndt Oberhauser
  • PET Imaging Agents
    Publication number: 20200017474
    Abstract: Preparation of novel 2-benzyl-5-methyl-2H-tetrazole derivatives of the formula (I) for use as PET imaging agents. The present invention relates to novel compounds of formula (I) their preparation and use as PET imaging agents for imaging techniques and diagnostics in the field of diseases and disorders mediated by or related to the enzyme autotaxin.
    Type: Application
    Filed: September 24, 2019
    Publication date: January 16, 2020
    Applicant: Novartis AG
    Inventors: Yves Auberson, Emmanuelle Briard, Darren Le Grand, Berndt Oberhauser
  • PET Imaging agents
    Patent number: 10450298
    Abstract: Preparation of novel 2-benzyl-5-methyl-2H-tetrazole derivatives of the formula (I) for use as PET imaging agents. The present invention relates to novel compounds of formula (I) their preparation and use as PET imaging agents for imaging techniques and diagnostics in the field of diseases and disorders mediated by or related to the enzyme autotaxin.
    Type: Grant
    Filed: January 20, 2016
    Date of Patent: October 22, 2019
    Assignee: Novartis AG
    Inventors: Yves Auberson, Emmanuelle Briard, Darren Le Grand, Berndt Oberhauser
  • PET Imaging Agents
    Publication number: 20180273509
    Abstract: Preparation of novel 2-benzyl-5-methyl-2H-tetrazole derivatives of the formula (I) for use as PET imaging agents. The present invention relates to novel compounds of formula (I) their preparation and use as PET imaging agents for imaging techniques and diagnostics in the field of diseases and disorders mediated by or related to the enzyme autotaxin.
    Type: Application
    Filed: January 20, 2016
    Publication date: September 27, 2018
    Applicant: Novartis AG
    Inventors: Yves Auberson, Emmanuelle Briard, Darren Le Grand, Berndt Oberhauser
  • Purine derivatives and their use in the treatment of disease
    Patent number: 9334271
    Abstract: The invention relates to PI3K inhibitors of the formula (I)• in which all of the variables are as defined in the specification, to their preparation, to their medical use, in particular to their use in the treatment of cancer and neurodegenerative disorders, and to medicaments comprising them.
    Type: Grant
    Filed: October 26, 2012
    Date of Patent: May 10, 2016
    Assignee: Novarits AG
    Inventors: Emmanuelle Briard, Pascal Furet, Andreas Lerchner, Peter Meier, Branko Radetich, David Andrew Sandham, Yanyi Zhu
  • NOVEL PURINE DERIVATIVES AND THEIR USE IN THE TREATMENT OF DISEASE
    Publication number: 20140336166
    Abstract: The invention relates to PI3K inhibitors of the formula (I) • in which all of the variables are as defined in the specification, to their preparation, to their medical use, in particular to their use in the treatment of cancer and neurodegenerative disorders, and to medicaments comprising them.
    Type: Application
    Filed: October 26, 2012
    Publication date: November 13, 2014
    Applicant: NOVARTIS AG
    Inventors: Emmanuelle Briard, Pascal Furet, Andreas Lerchner, Peter Meier, Branko Radetich, David Andrew Sandham, Yanyi Zhu
  • FTY720 HALOGENATED DERIVATIVES
    Publication number: 20120244071
    Abstract: There are provided new iodo- and bromo-compounds, and their use as diagnostic agents and imaging agents for diseases and disorders wherein S1P receptor expression is altered.
    Type: Application
    Filed: December 8, 2010
    Publication date: September 27, 2012
    Applicant: Novartis AG
    Inventors: Yves Auberson, Emmanuelle Briard, David Orain
  • Cyclic sulfones with aminobenzyl substitution useful as BACE inhibitors
    Patent number: 8093406
    Abstract: The invention relates to novel heterocyclic compounds of the formula in which all of the variables are as defined in the specification, in free form or in salt form, to their preparation, to their use as medicaments and to medicaments comprising them.
    Type: Grant
    Filed: July 9, 2009
    Date of Patent: January 10, 2012
    Assignee: Novartis AG
    Inventors: Emmanuelle Briard, Rainer Martin Lueoend, Rainer Machauer, Henrik Moebitz, Olivier Rogel, Jean-Michel Rondeau, Heinrich Rueeger, Marina Tintelnot-Blomley, Siem Jacob Veenstra
  • Cyclic sulfones with aminobenzyl substitution useful as BACE inhibitors
    Publication number: 20100056490
    Abstract: The invention relates to novel heterocyclic compounds of the formula in which all of the variables are as defined in the specification, in free form or in salt form, to their preparation, to their use as medicaments and to medicaments comprising them.
    Type: Application
    Filed: July 9, 2009
    Publication date: March 4, 2010
    Inventors: Emmanuelle Briard, Rainer Martin Lueoend, Rainer Machauer, Henrik Moebitz, Olivier Rogel, Jean-Michel Rondeau, Heinrich Rueeger, Marina Tintelnot-Blomley, Siem Jacob Veenstra
  • AMINOBENZYL-SUBSTITUTED CYCLIC SULFONES USEFUL AS BACE INHIBITORS
    Publication number: 20090054427
    Abstract: The invention relates to novel heterocyclic compounds of the formula in which all of the variables are as defined in the specification, in free form or in salt form, to their preparation, to their use as medicaments and to medicaments comprising them.
    Type: Application
    Filed: August 22, 2008
    Publication date: February 26, 2009
    Inventors: Emmanuelle Briard, Rainer Martin Lueoend, Rainer Machauer, Henrik Moebitz, Olivier Rogel, Jean-Michel Rondeau, Heinrich Rueeger, Marina Tintelnot-Blomley, Siem Jacob Veenstra
  • Radicicol Derivatives Useful for Position Emission Tomography
    Publication number: 20080311038
    Abstract: The present invention relates to novel radicicol derivatives of the formula I, in which R is R?, (CH2)nCOOR? or (CH2)nCONHR?, wherein R? is 11CH3, [3H]3C, [3H]2HC, [3H]H2C or (CH2)nHal, wherein Hal is 123I, 125I, 131I, I, 75Br, 76Br, 77Br, 82Br, Br, 18F or F, or R? is (CH2)n-1[3H]HCHal or (CH2)n-1[3H]2CHal, wherein Hal is I, Br or F, and n is, each independently, 1, 2, 3 or 4, in free form or in salt form, to their preparation, to their use as radiotracers/markers and to compositions containing them.
    Type: Application
    Filed: January 2, 2007
    Publication date: December 18, 2008
    Inventors: Yves Auberson, Mats Bergstroem, Emmanuelle Briard, Patrick Chene, Laurent Martarello, Joseph Schoepfer